Speaker Profile
MD, PhD, CMO, Velsera
Biography
Dr. Nagarajan has been a pioneer in genomics and informatics for 20+ years. He started at Washington University, the first CAPCLIA laboratory for clinical NGS, and where he facilitated clinical and translational research by integrating EHR, clinical trials, patient registry, biospecimen, and genomics data and by supporting complex multimodal analyses across these data types. As the Founder and President of Pierian, he built the Clinical Genomics Workspace (CGW), an endtoend disease, assay and instrument agnostic informatics solution used to process clinical NGS cases. At Velsera, Dr. Nagarajan leads the Knowledgebase team, which is responsible for curated clinical content that supports tertiary analysis in the CGW, and is responsible for regulatory submissions and for incubating and developing technology solutions to extend Velseras reach.
Talk
Optimizing Clinical Genomics with Velsera KB
The Velsera Knowledgebase (KB) streamlines the interpretation of clinical genomic test results, sensitively identifying important biomarkers and highlighting associated therapy options for comprehensive. In this session, we describe our practices for maintaining up-to-date genomic knowledge for solid tumors and hematological cancers and present approaches for benchmarking the KB’s performance, including against public databases, other curated knowledge sources, and real-world assessments by clinical molecular laboratories. We also showcase the adaptive learning capabilities of Velsera’s Clinical Genomics Workspace, which eliminates rework on recurrent biomarkers for faster sign out over time.
Clinical Dx Showcase:
Velsera
Velsera connects healthcare and life sciences to reveal the true promise of precision medicine—a continuous flow of knowledge between researchers, scientists and clinicians around the world, creating insights that radically improve human health.
Session Abstract – PMWC 2024 Silicon Valley
The PMWC 2024 Data Applications in Clinical Diagnostics Showcase will provide a 15-minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.
- Clinical Dx/Oncology (including Liquid Biopsy)
- Clinical Dx/Cardio Vascular
- Clinical Dx/Neurodegenerative
